A Case of Chronic Lymphocytic Leukemia Coinciding With COVID-19

被引:0
|
作者
Jeraiby, Mohammed A. [1 ]
机构
[1] Jazan Univ, Fac Med, Dept Med Biochem, Jazan, Saudi Arabia
关键词
covid-19; lymphocytosis; lymphocytosis chronic lymphocytic leukemia; leukemia; blood morphology; PATIENT;
D O I
10.7759/cureus.42522
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Comorbidities including leukemia are risk factors in coronavirus disease 2019 (COVID-19) patients for high morbidity and mortality. The severity of the disease is usually correlated with lymphopenia. On the other hand, we came across a case of marked absolute lymphocytosis in a COVID-19 patient, which further escalated five-fold during his hospital stay. Subsequently, the diagnosis of chronic lymphocytic leukemia (CLL) was made following positive cell surface markers for CD19+, CD5+, and CD20+ (dim), in the presence of restricted immunoglobulin light chain of lambda type on flow cytometry. Numerous cases are available in the literature of COVID-19 among established CLL patients. However, we are mentioning here the second case where the diagnosis of CLL was established accidentally during the work-up for lymphocytosis in COVID-19 infection.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] COVID-19 Immunization in a Chronic Lymphocytic Leukemia Patient Lacking Response to Initial Vaccination.
    De De Jesus, Katherine Garcia
    Weltz, Jonathan
    Schneider, Jeffrey
    Braunstein, Marc
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 : S16 - S17
  • [22] Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia
    Lyski, Zoe L.
    Kim, Myung S.
    Lee, David Xthona
    Raue, Hans-Peter
    Raghunathan, Vikram
    Griffin, Janet
    Ryan, Debbie
    Brunton, Amanda E.
    Curlin, Marcel E.
    Slifka, Mark K.
    Messer, William B.
    Spurgeon, Stephen E.
    BLOOD ADVANCES, 2022, 6 (04) : 1207 - 1211
  • [23] COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
    Simkovic, Martin
    Turcsanyi, Peter
    Spacek, Martin
    Mihalyova, Jana
    Ryznerova, Pavlina
    Maco, Maria
    Vodarek, Pavel
    Ecsiova, Dominika
    Poul, Hynek
    Mocikova, Heidi
    Zuchnicka, Jana
    Panovska, Anna
    Lekaa, Mohammad
    Orsulova, Martina
    Prchlikova, Adela
    Stejskal, Lukas
    Maslejova, Stanislava
    Brychtova, Yvona
    Bezdekova, Lucie
    Papajik, Tomas
    Lysak, Daniel
    Trneny, Marek
    Smolej, Lukas
    Doubek, Michael
    ANNALS OF HEMATOLOGY, 2023, 102 (04) : 811 - 817
  • [24] Understanding the Impact of COVID-19 on Chronic Lymphocytic Leukemia (CLL) Caregiving and Related Resource Needs
    Bagautdinova, Diliara
    Bacharz, Kelsey C.
    Bylund, Carma L.
    Sae-Hau, Maria
    Weiss, Elisa S.
    Rajotte, Michelle
    Lincoln, Greg
    Vasquez, Taylor S.
    Parker, Naomi D.
    Wright, Kevin B.
    Fisher, Carla L.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (04)
  • [25] COVID-19 vaccines elicit robust cellular immunity and clinical protection in chronic lymphocytic leukemia
    Parry, Helen
    Bruton, Rachel
    Roberts, Thomas
    McIlroy, Graham
    Damery, Sarah
    Sylla, Panagiota
    Dowell, Alexander C.
    Tut, Gokhan
    Lancaster, Tara
    Bone, David
    Willett, Brian
    Logan, Nicola
    Scott, Sam
    Hulme, Sam
    Jadir, Azar
    Amin, Umayr
    Nicol, Sam
    Stephens, Christine
    Faustini, Sian
    Al-Taei, Saly
    Richter, Alex
    Blakeway, Daniel
    Verma, Kriti
    Margielewska-Davies, Sandra
    Pearce, Hayden
    Pratt, Guy
    Zuo, Jianmin
    Paneesha, Shankara
    Moss, Paul
    CANCER CELL, 2022, 40 (06) : 584 - 586
  • [26] Concurrent chronic lymphocytic leukemia and COVID-19: A comprehensive review of epidemiological, diagnostic, and therapeutic challenges
    Roosta, Yousef
    Behzadi, Farhad
    Askari, Elham
    Raeisi, Mortaza
    Mehr, Amin Danandeh
    Nouri-Vaskeh, Masoud
    LEUKEMIA RESEARCH REPORTS, 2021, 15
  • [27] Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
    Cuneo, Antonio
    Scarfo, Lydia
    Reda, Gianluigi
    Varettoni, Marzia
    Quaglia, Francesca Maria
    Marchetti, Monia
    De Paoli, Lorenzo
    Re, Francesca
    Pietrasanta, Daniela
    Rigolin, Gian Matteo
    Orsucci, Lorella
    Ibatici, Adalberto
    Gattei, Valter
    Mauro, Francesca R.
    Trentin, Livio
    Laurenti, Luca
    Marasca, Roberto
    Foa, Robin
    BLOOD, 2020, 136 (06) : 763 - 766
  • [28] Ibrutinib interferes with innate immunity in chronic lymphocytic leukemia patients during COVID-19 infection
    Fiorcari, Stefania
    Atene, Claudio Giacinto
    Maffei, Rossana
    Debbia, Giulia
    Potenza, Leonardo
    Luppi, Mario
    Marasca, Roberto
    HAEMATOLOGICA, 2021, 106 (08) : 2265 - 2268
  • [29] COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group
    Martin Šimkovič
    Peter Turcsányi
    Martin Špaček
    Jana Mihályová
    Pavlína Ryznerová
    Mária Maco
    Pavel Vodárek
    Dominika Écsiová
    Hynek Poul
    Heidi Móciková
    Jana Zuchnická
    Anna Panovská
    Mohammad Lekaa
    Martina Oršulová
    Adéla Prchlíková
    Lukáš Stejskal
    Stanislava Mašlejová
    Yvona Brychtová
    Lucie Bezděková
    Tomáš Papajík
    Daniel Lysák
    Marek Trněný
    Lukáš Smolej
    Michael Doubek
    Annals of Hematology, 2023, 102 : 811 - 817
  • [30] Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy:a case report
    Cecyn, Karin Zattar
    Marques, Mariana Oliveira
    Rodrigues, Milena Almendra
    Brito, Fabio Nascimento
    Baiocchi, Otavio Cesar Carvalho Guimaraes
    BLOOD RESEARCH, 2021, 56 (03) : 197 - 201